Acne Treatment Market Size to Reach USD 15,183.2 Million By 2032| Precedence Research

OTTAWA, ON, Dec. 11, 2023 /PRNewswire/ -- The global acne treatment market size is estimated to reach around USD 15,183.2 million by 2032, increasing from USD 10,043.1 million in 2023, expanding at a CAGR of 4.8% from 2023 to 2032.

The North America acne treatment market size was valued at USD 4,355.3 million in 2022 and is estimated to surpass around USD 7,123.1 million by 2032, growing at a CAGR of 5.2% during the future period 2023 to 2032.

The Europe acne treatment market size surpassed USD 2,592.5 million in 2022 and is estimated to hit around USD 4,115.1 million by 2032, growing at a CAGR of 4.9% during the future period 2023 to 2032.

The Asia Pacific acne treatment market size was evaluated at USD 1,750.9 million in 2022 and is estimated to hit around USD 2,656.8 million by 2032, growing at a CAGR of 4.4% from 2023 to 2032.

The LAMEA acne treatment market size reached USD 962.8 million in 2022 and is estimated to surpass around USD 1,288.2 million by 2032, growing at a CAGR of 3.1% from 2023 to 2032.

Immediate Delivery Available | Buy This Premium Research Report@
https://www.precedenceresearch.com/sample/2094

Acne is a skin condition characterized by inflammation involving the interaction of sebaceous (oil) glands and hair follicles, each containing fine hair. Sebaceous glands produce sebum, which exits the skin through pores, which are apertures in the follicles. Keratinocytes, a kind of skin cell, line the follicles. Keratinocytes move to the skin surface as the body sheds skin cells under normal conditions. Hair, sebum, and keratinocytes adhere within the pores in acne patients, limiting regular shedding and preventing sebum from reaching the skin's surface.

The combination of oil and cells provides an environment where bacteria, generally found on the skin, grow, resulting in inflammation characterized by swelling, redness, heat, and discomfort; when the clogged follicle's wall ruptures, germs, skin cells, and sebum are released into the surrounding skin, resulting in lesions or pimples. According to a 2022 article in the British Journal of Dermatology, acne vulgaris affects about 9.4% of the world's population.

Acne treatment market is segmented based on product, acne type, treatment, drug type, gender, route of administration, end -user and region. Factors such as the high prevalence of acne, increasing awareness, rising disposable income, and growing demand for Over the Counter (OTC) products, focus on personalized medicine, are driving the growth of the market.  However, the high cost of treatment, side effects and adverse reactions, lack of awareness and misconceptions, and stringent regulatory requirements limit growth.

Immediate Delivery Available | Buy This Premium Research Report@
https://www.precedenceresearch.com/checkout/2094

Growth factors

• The unhealthy lifestyle which is followed by the people also helps to boost the market for acne treatment.
• The increasing importance of aesthetics among the people has boosted the market for acne treatment.
• The increasing demand for a brighter and glowing skin appearance has propelled the market for acne treatment.
• The prevalence of acne among the infants and the younger age group has boosted the market for acne treatment.
• The particular skin disorder is also considered to have genetic implications which require special attention.
• In order to obtain a perfect skin texture various types of treatment ranging from the use of retinoids to having a plastic surgery done have been considered by the people.
• The increasing number of products that manage the oil secretion of the skin and help to maintain the pH balance have boosted the market for acne treatment.

Regional Snapshot:

North America dominated the market with a high market share of about 45.08%. It was valued at USD 4.35 billion in 2022. The reason behind its dominance is its prevalence of acne, advanced healthcare facilities, technological adoption, and consumer awareness. The region has a high prevalence of acne due to the changing lifestyle. Moreover, Recent studies have shown that an individual with acne in the United States spends an average of $150 to $200 a year of personal costs for over-the-counter products. Acne diagnosis and treatment have increased largely due to North America's well-established healthcare system, which includes access to advanced healthcare resources and skincare specialists. Furthermore, the area adopts dermatology technology advancements promptly, which creates a need for advanced acne treatments. The market is additionally impacted by a relatively affluent consumer base, high awareness and education about skincare and dermatological conditions.

The market is additionally impacted by a relatively affluent consumer base, high awareness and education about skincare and dermatological conditions. The presence of numerous pharmaceutical and skincare companies boosts rivalry and continuous innovation, leading to a diverse range of acne treatment products and services.

Personalized your customization here:
https://www.precedenceresearch.com/customization/2094

Acne Treatment Market Revenue by Product, (US$ Million)

The devices segment is expected to grow faster during the forecast period. Laser devices have grown significantly, owing to technological developments and the precision these devices provide. Lasers, like traditional treatments, can selectively target sebaceous glands, providing an efficient approach for eliminating acne lesions while not negatively affecting adjacent skin. Continuous advancements in laser technology have created safer and more efficient devices, increasing the range of acne severities that can be treated. Laser devices have become a preferred option for persons seeking non-invasive and focused acne treatments due to their low systemic adverse effects and pain.

Moreover, radiofrequency devices are expected to grow rapidly owing to their ability to induce collagen production and contribute to overall skin health. This collagen stimulation additionally aids in healing; however, it also has the potential to improve the appearance of acne scars. The appealing features of radiofrequency devices have been strengthened by their low downtime, which aligns with the desires of people who want efficient acne treatment without large disturbances to their everyday lives. Furthermore, as radiofrequency devices complement other acne therapies, such as topical medicines and chemical peels, these are crucial components of a complete and multi-faceted strategy for acne care.

You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 650 460 3308

Acne Treatment Market Revenue, By Treatment Type (US$ Million)

The medication segment dominated the market in 2022, holding the maximum share of the acne treatment market. Medication is the most common kind of acne treatment, and it includes a wide range of therapeutic alternatives, such as antibiotics, retinoid therapy, hormone medicines, anti-inflammatory drugs, and chemical peels. This dominance is based on drugs' proven efficacy and adaptability in treating acne, including bacterial infection, sebum control, inflammation, and hormone abnormalities. Medications play an important role due to their adaptability across different acne severity levels, with antibiotics targeting inflammatory acne, retinoids addressing comedonal acne, and hormone medications proving beneficial in certain forms of hormonal acne.

Considering the advent of treatment devices such as lasers and radiofrequency devices, pharmaceuticals continue to serve as the foundation of acne therapy, as evidenced by ongoing developments, combination therapies, and their extensive use in treating this common dermatological problem.

Acne Treatment Market Report Scope

Market Dynamics

Driver: The growing understanding of genetic factors impacting acne is driving the growth of the market. There is an increasing awareness that genetic implications demand additional investigation in the development of targeted therapeutics as research into the genetic foundations of this skin condition progresses. A new era of individualized treatments has begun with identifying genes and pathways linked to acne susceptibility, offering more efficient and customized remedies for those inclined to the condition. The focus on hereditary variables advances understanding of the complexity of acne and drives an upsurge of research and innovation that advances the acne therapy market.

Restraint: A risk of negative responses and side effects from different drugs is a major barrier to using acne treatments. For instance, oral antibiotics result in sensitivity and upset stomach, while topical retinoids and benzoyl peroxide induce skin redness, dryness, and increased sensitivity to sunlight. Prolonged usage of antibiotics may render people more vulnerable to yeast infections, especially women. Furthermore, it's crucial to use caution when mixing some acne treatments because benzoyl peroxide and some topical retinoids have an interaction that might reduce their respective results. These limitations indicate how crucial it is for patients and healthcare professionals to carefully assess and monitor potential hazards, maximize the efficacy of acne therapies, and place patients' safety and well-being first.

Opportunity: The recent advancement in laser technology presents a significant opportunity for the acne treatment market. Historically, lasers were not an integral component of acne treatment due to concerns about efficiency. However, the landscape is evolving, with new lasers and devices emerging as promising options for treating acne. The FDA has approved the 1,726 nm and 1,064 nm lasers for treating mild to severe acne, which has resulted in attention. These lasers selectively damage sebaceous glands, offering a novel approach to acne management. Positive results from clinical trials have been shown, such as improvements on the IGA scale and significant drops in the number of inflammatory lesions. Comparing the FDA-cleared 1,064 nm laser for mild to moderate inflammatory acne to a sham treatment, the 650 µsecond laser demonstrated an advantage in decreasing inflammatory lesions. While laser treatments are unlikely to be able to completely replace prescription drugs but are expected to be an alternative for people with acne. This trend toward using advanced laser technologies in acne therapy signifies a developing and inventive sector within the larger acne treatment market.

Browse More Insights:

Anti-aging Market: The global anti-aging market was estimated at US$ 64 billion in 2022 and is expected to surpass around US$ 121.8 4billion by 2032, poised to grow at a CAGR of 6.70% from 2023 to 2032.

Health and Wellness Market: The global health and wellness market was valued at USD 5,243.3 billion in 2022 and is expected to reach over USD 8,945.3 billion by 2032, growing at a CAGR of 5.5% from 2023 to 2032.

Anti-Aging Cosmetics Market: The global anti-aging cosmetics market size was estimated at USD 50.48 billion in 2022 and it is expected to hit around USD 90.32 billion by 2032, poised to grow at a CAGR of 5.99% from 2023 to 2032.

Functional Cosmetics Market: The global functional cosmetics market size was estimated at USD 3.5 billion in 2022 and is expected to hit around USD 6.06 billion by 2032, expanding at a CAGR of 5.7% from 2023 to 2032.

Premium Cosmetics Market: The global premium cosmetics market size was estimated at USD 116.3 billion in 2022 and is projected to hit around USD 197.76 billion by 2032 with a registered CAGR of 6.1% from 2023 to 2032.

Herbal Beauty Products Market: The global herbal beauty products market size was estimated at US$ 85 billion in 2022 and is expected to hit US$ 137.79 billion by 2032, foreseen to register a growth at a CAGR of 5% from 2023 to 2032.

Baby Skincare Market: The global baby skincare market size was valued at US$ 15 billion in 2022 and is expected to hit US$ 27.76 billion by 2032 poised to grow at a CAGR of 6.40% during the forecast period 2023 to 2032.

Skincare Devices Market: The global skincare devices market size surpassed USD 15.6 billion in 2022 and is projected to hit around USD 43.31 billion by 2032, exhibiting a CAGR of 10.80% during the forecast period from 2023 to 2032.

Recent Developments:

• Dec 2023, The Mount Sinai Winter Symposium reviewed recent breakthroughs in acne therapy. A topical gel with an antibiotic, retinoid, and antimicrobial agent that the FDA has approved was highlighted. Antibiotic resistance concerns spurred a push for alternatives such as sarecycline. Treatment that lasted more than 12 weeks was recommended for improved results. Light-based devices, for example, have shown efficacy and safety in decreasing acne lesions. Laser treatments, including a 1726 nm laser, were shown to be effective without producing hyperpigmentation in people with darker skin.
• March 2023, The FDA approved Cabtreo (clindamycin 1.2%/adapalene 0.15%/benzoyl peroxide 3.1%) for treating acne vulgaris in patients aged 12 and older. This marks the first fixed-dose, triple-combination treatment for acne approved by the FDA. Clinical trials successfully reduced inflammatory and noninflammatory lesions, with mild to moderate adverse events. Dermatologists view Cabtreo as a potential first-option treatment due to its efficacy and simplified once-daily dosing.
• August 2023, Zydus Lifesciences announced the FDA approval to market generic product to treat acne in the American market.
• Sept 2023, Glenmark Pharmaceuticals has signed distribution and license agreements with Cosmo Pharmaceuticals for acne treatment ointment Winlevi in Europe and South Africa. Winlevi, approved by the USFDA for topical acne treatment, will be commercialized exclusively by Glenmark in 15 EU countries, South Africa, and the UK. Cassiopea, a subsidiary of Cosmo, will handle marketing authorization at the EMA, while Glenmark will be responsible for registration in South Africa and the UK. Cosmo will be the exclusive supplier, receiving an upfront payment of USD 5 million, milestones, and double-digit royalties on net sales.
• March 2022, Galderma Introduces a Breakthrough Acne Skincare Cream. Twyneo Cream is the first and only 0.1% tretinoin and 3% benzoyl peroxide (BPO) 2-in-1 treatment proven to cure moderate to severe face acne fast. Patented microencapsulation technology combines two previously unrelated substances and allows for controlled release to produce visible results in as little as two weeks.

Key Market Players:

• PHYTOMER
• Skin Medica
• PCA
• Obaji
• Skin Better Science
• Colorescience
• Revision Skincare
• The BeautyHealth Company
• Sente
• Jan Marini Skin Research
• Glow Biotics LLC
• Perricone MD

Key Market Segments

By Product

• Therapeutic Treatment
• Antibiotics
• Retinoid Therapy
• Hormonal Drugs
• Anti-inflammatory Drugs
• Chemical Peels
• Devices
• Laser Devices
• Radio frequency Devices 

By Acne Type

• Moderate
• Mild
• Moderate To Severe

By Treatment

• Medication
• Therapeutic Devices

By Drug Type

• Over the Counter (OTC) 
• Prescription 

By Gender 

• Women
• Men

By Route of Administration

• Topical
• Oral
• Injectable 

By End User

• Dermatology Clinics
• MedSpa

By Geography

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa (MEA)

Immediate Delivery Available | Buy This Premium Research Report@
https://www.precedenceresearch.com/checkout/2094

You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 650 460 3308

Unlocking Market Insights through Data Excellence 

The "Precedence Statistics" flexible dashboard is a powerful tool that offers real-time news updates, economic and market forecasts, and customizable reports. It can be configured to support a wide range of analysis styles and strategic planning needs. This tool empowers users to stay informed and make data-driven decisions in various scenarios, making it a valuable asset for businesses and professionals looking to stay ahead in today's dynamic and data-driven world. 

Access our Premium Real Time Data Intelligence Tool, Visit: www.precedencestatistics.com

About Us

Precedence Research is a worldwide market research and consulting organization. We give an unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.

Web: https://www.precedenceresearch.com

Our Blogs:
https://www.towardshealthcare.com
https://www.towardspackaging.com

For Latest Update Follow Us:
Linkedin | Facebook | Twitter

Logo: https://mma.prnewswire.com/media/2264617/Precedence_Research_Logo.jpg